A Collaborative Initiative for Health Export Growth

HealthCatalyst comprising Norway Health Tech, Oslo Cancer Cluster, Validé (Norwegian Smart Care Cluster), and The Life Science Cluster work together with Innovation Norway and the rest of team Norway to implement the Norwegian government’s health initiative in Germany under the national export reform program, The Whole of Norway Exports.

Germany has been identified as a priority market for Norwegian health technology companies seeking to scale their international presence. This initiative will concentrate on a curated group of companies with established export revenues and strong potential for growth in Germany. These companies, collectively referred to as the landslagsliste by Innovation Norway, will receive targeted support to strengthen their market position and accelerate export expansion. See what Innovation Norway says about the inititative

Targeted Support for Norwegian Companies

To ensure a need driven approach Healthcatalyst performed 1:1 interviews with all companies on the ‘landslagsliste’. Building on this input HealthCatalyst in collaboration with Innovation Norway, the embassy and Team Norway in Germany have launched several initiatives in 2025. For details see here!

The program will continue in 2026, and the plan will be published soon.

We are looking forward to continue this project in 2026, and the plan will be published soon!

Please reach out with questions or suggestions to:

Project manager: Arild Kristensen, Norway Health Tech, arild.kristensen@norwayhealthtech.com +47 90532591

Jutta Heix, Oslo Cancer Cluster, jh@oslocancercluster.no +47 94163089

Trine Radmann, Norway Health Tech, trine.radmann@norwayhealthtech.com + 47 99269285

Shokouh Makvandi-Nejad, The Life Science Cluster, shokouh@tlsc.no +47 921 37 037

Martin Nietz, Innovation Norway Germany, martin.nietz@innovationnorway.no +49171 4260170

Tone Varslot Stave, Innovation Norway Oslo, tone.varslot.stave@innovationnorway.no +4795225533